Praiss AM

No ORCID on file · 2 papers in corpus
2024
Gynecologic Oncology ·doi:10.1016/j.ygyno.2024.01.015

ObjectivesMesonephric (MA) and mesonephric-like (MLA) adenocarcinomas are rare cancers, and data on clinical behavior and response to therapy are limited. We sought to report molecular features, treatment, and outcomes of MA/MLA from a sing…

2023
Gynecologic Oncology ·doi:10.1016/j.ygyno.2023.10.013

ObjectiveTo assess the impact of short-term postoperative complications on oncologic outcomes for patients with epithelial ovarian cancer undergoing primary cytoreductive surgery (PCS) or interval cytoreductive surgery (ICS) with intestinal…